CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects - PubMed (original) (raw)
. 2001 May;107(10):1303-10.
doi: 10.1172/JCI12433.
T Dong, F A Plummer, J Kimani, T Rostron, P Kiama, E Njagi, E Irungu, B Farah, J Oyugi, R Chakraborty, K S MacDonald, J J Bwayo, A McMichael, S L Rowland-Jones
Affiliations
- PMID: 11375420
- PMCID: PMC209302
- DOI: 10.1172/JCI12433
CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects
R Kaul et al. J Clin Invest. 2001 May.
Abstract
HIV-1-specific cytotoxic T-lymphocyte (CTL) responses have been detected at a low frequency in many HIV-1-exposed, persistently seronegative (HEPS) subjects. However, it is unclear how CTLs could protect against HIV acquisition in HEPS subjects, when high levels of circulating CTL fail to prevent disease progression in most seropositive subjects. To address this issue we studied CD8(+) lymphocyte responses to a panel of HIV-1 CTL epitopes in 91 HEPS and 87 HIV-1-infected Nairobi sex workers. HIV-specific responses in seropositive women focused strongly on epitopes rarely or never recognized in HEPS subjects, who targeted epitopes that were subdominant or unrecognized in infected women. These differences in epitope specificity were restricted by only those HLA class I alleles that are associated with a reduced risk of HIV-1 infection in this cohort. Late seroconversion in HEPS donors was associated with a switch in epitope specificity and/or immunodominance to those epitopes preferentially recognized by HIV-1-infected women. The likelihood of detecting HIV-1-specific responses in HEPS women increased with the duration of viral exposure, suggesting that HIV-1-specific CD8(+) responses are acquired over time. The association between differential recognition of distinct CTL epitopes and protection from HIV-1 infection may have significant implications for vaccine design.
Figures
Figure 1
Association between duration of previous HIV-1 exposure and HIV-1–specific IFN-γ ELISPOT responses in HEPS sex workers. HIV-1–seronegative sex workers (n = 91) were divided into three groups, according to the duration of enrollment in the sex worker cohort: ≥3 years (group 1; n = 67); 1–3 years (group 2; n = 16); <1 year (group 3; n = 8). Group 4 consisted of 18 HIV-1–seronegative Kenyan women with no history of commercial sex work. The vertical bars represent the percentage of each group demonstrating HIV-1 CTL epitope-specific ELISPOT responses (see text for definition).
Similar articles
- New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers.
Kaul R, Rowland-Jones SL, Kimani J, Fowke K, Dong T, Kiama P, Rutherford J, Njagi E, Mwangi F, Rostron T, Onyango J, Oyugi J, MacDonald KS, Bwayo JJ, Plummer FA. Kaul R, et al. Immunol Lett. 2001 Nov 1;79(1-2):3-13. doi: 10.1016/s0165-2478(01)00260-7. Immunol Lett. 2001. PMID: 11595284 - HIV-specific cytotoxic T lymphocytes, HLA-A11, and chemokine-related factors may act synergistically to determine HIV resistance in CCR5 delta32-negative female sex workers in Chiang Rai, northern Thailand.
Sriwanthana B, Hodge T, Mastro TD, Dezzutti CS, Bond K, Stephens HA, Kostrikis LG, Limpakarnjanarat K, Young NL, Qari SH, Lal RB, Chandanayingyong D, McNicholl JM. Sriwanthana B, et al. AIDS Res Hum Retroviruses. 2001 May 20;17(8):719-34. doi: 10.1089/088922201750236997. AIDS Res Hum Retroviruses. 2001. PMID: 11429112 - How important is the 'quality' of the cytotoxic T lymphocyte (CTL) response in protection against HIV infection?
Rowland-Jones SL, Pinheiro S, Kaul R, Hansasuta P, Gillespie G, Dong T, Plummer FA, Bwayo JB, Fidler S, Weber J, McMichael A, Appay V. Rowland-Jones SL, et al. Immunol Lett. 2001 Nov 1;79(1-2):15-20. doi: 10.1016/s0165-2478(01)00261-9. Immunol Lett. 2001. PMID: 11595285 - Insights into the role of host genetic and T-cell factors in resistance to HIV transmission from studies of highly HIV-exposed Thais.
McNicholl JM, Promadej N. McNicholl JM, et al. Immunol Res. 2004;29(1-3):161-74. doi: 10.1385/IR:29:1-3:161. Immunol Res. 2004. PMID: 15181279 Review. - Therapeutic Vaccine Against HIV, Viral Variability, Cytotoxic T Lymphocyte Epitopes, and Genetics of Patients.
Fleury H, Tumiotto C, Bellecave P, Recordon-Pinson P. Fleury H, et al. AIDS Res Hum Retroviruses. 2018 Jan;34(1):27-30. doi: 10.1089/aid.2017.0175. Epub 2017 Oct 12. AIDS Res Hum Retroviruses. 2018. PMID: 28899104 Review.
Cited by
- Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation.
Yusim K, Kesmir C, Gaschen B, Addo MM, Altfeld M, Brunak S, Chigaev A, Detours V, Korber BT. Yusim K, et al. J Virol. 2002 Sep;76(17):8757-68. doi: 10.1128/jvi.76.17.8757-8768.2002. J Virol. 2002. PMID: 12163596 Free PMC article. - Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
Currier JR, deSouza M, Chanbancherd P, Bernstein W, Birx DL, Cox JH. Currier JR, et al. J Virol. 2002 May;76(10):4971-86. doi: 10.1128/jvi.76.10.4971-4986.2002. J Virol. 2002. PMID: 11967314 Free PMC article. - Mucosa: Key Interactions Determining Sexual Transmission of the HIV Infection.
Gonzalez SM, Aguilar-Jimenez W, Su RC, Rugeles MT. Gonzalez SM, et al. Front Immunol. 2019 Feb 6;10:144. doi: 10.3389/fimmu.2019.00144. eCollection 2019. Front Immunol. 2019. PMID: 30787929 Free PMC article. Review. - Differences in HIV-specific T cell responses between HIV-exposed and -unexposed HIV-seronegative individuals.
Ritchie AJ, Campion SL, Kopycinski J, Moodie Z, Wang ZM, Pandya K, Moore S, Liu MK, Brackenridge S, Kuldanek K, Legg K, Cohen MS, Delwart EL, Haynes BF, Fidler S, McMichael AJ, Goonetilleke N. Ritchie AJ, et al. J Virol. 2011 Apr;85(7):3507-16. doi: 10.1128/JVI.02444-10. Epub 2011 Jan 26. J Virol. 2011. PMID: 21270166 Free PMC article. - Impaired viral entry cannot explain reduced CD4+ T cell susceptibility to HIV type 1 in certain highly exposed individuals.
Speelmon EC, Livingston-Rosanoff D, Desbien AL, Lee J, Wick WD, Hladik F, McElrath MJ. Speelmon EC, et al. AIDS Res Hum Retroviruses. 2008 Nov;24(11):1415-27. doi: 10.1089/aid.2007.0256. AIDS Res Hum Retroviruses. 2008. PMID: 19000021 Free PMC article.
References
- Rowland-Jones SL, McMichael A. Immune responses in HIV-exposed seronegatives: have they repelled the virus? Curr Opin Immunol. 1995;7:448–455. - PubMed
- Haynes BF, Pantaleo G, Fauci AS. Toward an understanding of the correlates of protective immunity to HIV infection. Science. 1996;271:324–328. - PubMed
- Clerici M, Shearer GM. Correlates of protection in HIV infection and the progression of HIV infection to AIDS. Immunol Lett. 1996;51:69–73. - PubMed
- Letvin NL. Progress in the development of an HIV-1 vaccine. Science. 1998;280:1875–1880. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials